Jennifer L. Lund, PhD
Jennifer L. Lund, PhD
Her geriatric oncology research addresses: 1) the quality of cancer care, 2) the effectiveness and safety of cancer treatments and 3) the role of polypharmacy, multimorbidity, and frailty in cancer treatment selection and outcomes.
Dr. Lund has worked extensively with the Surveillance, Epidemiology and End Results program (SEER) Medicare data to examine patterns of chemotherapy uptake and investigate multilevel factors associated with the dissemination of innovative treatments among older cancer patients. She also has amassed international experience using large linked databases in Canada and Denmark.
Honors and AwardsDesignated a Fellow of the International Society for Pharmacoepidemiology (FISPE)
2021, International Society for PharmacoepidemiologyYoung Investigator Award Finalist
2019, International Society for Geriatric OncologyGordon H. DeFriese Career Development in Aging Research Award
2015, Institute on Aging, University of North Carolina at Chapel Hill
EPID 766: Epidemiologic Research Using Healthcare Databases | Syllabus
This course teaches students how to use administrative healthcare utilization data for epidemiologic studies.
Health services research
Comparative effectiveness and safety research
Geriatric oncology research
Member, PhD Admissions Committee, Department of Epidemiology (2019-present)
Member, Graduate Studies Committee, Department of Epidemiology (2014-2018)
Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model. Lund JL, Duberstein PR, Loh KP, Gilmore N, Plumb S, Lei L, Keil AP, Islam JY, Hanson LC, Giguere JK, Vogel VG, Burnette BL, Mohile SG Journal of Geriatric Oncology (In-Press).
Effects of Anticholinergic and Sedative Medication Use on Fractures: A Self-Controlled Design Study. . Shmuel S, Pate V, Pepin MJ, Bailey JC, Golightly YM, Hanson LC, Stürmer T, Naumann RB, Gnjidic D, Lund JL. Journal of the American Geriatrics Society (In-Press)..
Introducing Longitudinal Cumulative Dose to Describe Chemotherapy Patterns Over Time: Case Study of a Colon Cancer Trial. . Webster-Clark MA, Keil AP, Sanoff HK, Sturmer T, Westreich D, Lund JL. (1970). International Journal of Cancer, 149(2), 394-402.
Adherence to Endocrine Therapy Including Ovarian Suppression: A Large Observational Cohort Study of US Women with Early Breast Cancer. Cancer. . Reeder-Hayes KE, Mayer SE, Lund JL. (1970). Cancer, 127(8), 1220-1227.
Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study. Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, Lund JL (co-senior authors) (2021). Journal of National Comprehensive Cancer Network.
Effectiveness of adjuvant FOLFOX vs 5FU/LV in adults over age 65 with stage II and III colon cancer using a novel hybrid approach. Lund JL, Webster-Clark MA, Hinton SP, Shmuel S, Stürmer T, Sanoff HK. (2020). Pharmacoepidemiology and Drug Safety, 29(12), 1579-1587.
Validation of a 5-Year Mortality Prediction Model among U.S. Medicare Beneficiaries. . Ross RK, Kuo TM, Webster-Clark M, Lewis CL, Kistler CE, Jonsson Funk M, Lund JL. (2020). Journal of the American Geriatrics Society, 68(12), 2898-2902.
BA, Quantitative Economics/International Relations, Tufts University, 2003
MSPH, Epidemiology, The University of North Carolina at Chapel Hill, 2009
PhD, Epidemiology, The University of North Carolina at Chapel Hill, 2011